VIR BIOTECHNOLOGY INC shareholders Q3 2023

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
GSA CAPITAL PARTNERS LLP 117,131$1,0980.09%
Salvus Wealth Management, LLC 11,691$109,5450.09%
Edgestream Partners, L.P. 106,808$1,000,7910.08%
JUPITER ASSET MANAGEMENT LTD 708,257$6,636,3680.07%
XTX Topco Ltd 44,205$414,2010.07%
DCF Advisers, LLC 10,000$93,7000.05%
Clarius Group, LLC 57,193$535,8980.05%
PROFUND ADVISORS LLC 91,038$853,0260.05%
Y-Intercept (Hong Kong) Ltd 42,266$396,0320.04%
Vise Technologies, Inc. 15,861$148,6180.04%
External links

This page lists VIR BIOTECHNOLOGY INC's shareholders in Q3 2023. To view VIR BIOTECHNOLOGY INC's shareholder history, click here.